AllovirInc Stock Financials

ALVR
 Stock
  

USD 7.13  0.02  0.28%   

You can use AllovirInc fundamental data analysis to find out if markets are presently mispricing the company. We were able to interpolate and analyze data for thirty-three available fundamental indicators for AllovirInc, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all AllovirInc financials, including its book value per share, and the relationship between the net income and number of employees . Given that AllovirInc has a gross profit of 165 K, we suggest you to validate AllovirInc prevailing market performance to make sure the company can sustain itself down the road. Use AllovirInc to enhance the returns of your portfolios. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a normal upward fluctuation. Check odds of AllovirInc to be traded at $7.49 in 90 days.
  
With this module, you can analyze AllovirInc financials for your investing period. You should be able to track the changes in AllovirInc individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

AllovirInc Most Recent Estimates

EPS Estimate Next Quarter
(0.57) 
Diluted Eps
(2.92) 
EPS Estimate Current Year
(2.30) 
EPS Estimate Next Year
(2.24) 
EPS Estimate Current Quarter
(0.53) 
Earnings Share
(2.92) 
Understanding current and past AllovirInc Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AllovirInc's financial statements are interrelated, with each one affecting the others. For example, an increase in AllovirInc's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Less than 26
AllovirInc has less than 26 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for AllovirInc stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in AllovirInc's official financial statements usually reflect AllovirInc's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of AllovirInc. For example, before you start analyzing numbers published by AllovirInc accountants, it's critical to develop an understanding of what AllovirInc's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of AllovirInc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AllovirInc's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in AllovirInc's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AllovirInc. Please utilize our Beneish M Score to check the likelihood of AllovirInc's management to manipulate its earnings.

AllovirInc Company Summary

AllovirInc competes with Johnson Johnson, Bondbloxx ETF, Fidelity MSCI, and Merck. Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell therapies to prevent and treat devastating viral-associated diseases. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts. Allovir operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS0198181036
Business Address1100 Winter Street,
SectorBiotechnology
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.allovir.com
Phone617 433 2605
CurrencyUSD - US Dollar
You should never invest in AllovirInc without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AllovirInc Stock, because this is throwing your money away. Analyzing the key information contained in AllovirInc's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

AllovirInc Key Financial Ratios

Generally speaking, AllovirInc's financial ratios allow both analysts and investors to convert raw data from AllovirInc's financial statements into concise, actionable information that can be used to evaluate the performance of AllovirInc over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that AllovirInc reports annually and quarterly.

AllovirInc Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AllovirInc's current stock value. Our valuation model uses many indicators to compare AllovirInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AllovirInc competition to find correlations between indicators driving AllovirInc's intrinsic value. More Info.
AllovirInc is rated second in debt to equity category among related companies. It is rated second in total asset category among related companies fabricating about  2,018,267,606  of Total Asset per Debt to Equity. . Comparative valuation analysis is a catch-all model that can be used if you cannot value AllovirInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AllovirInc's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AllovirInc's earnings, one of the primary drivers of an investment's value.

AllovirInc Systematic Risk

AllovirInc's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AllovirInc volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on AllovirInc correlated with the market. If Beta is less than 0 AllovirInc generally moves in the opposite direction as compared to the market. If AllovirInc Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AllovirInc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AllovirInc is generally in the same direction as the market. If Beta > 1 AllovirInc moves generally in the same direction as, but more than the movement of the benchmark.
.

About AllovirInc Financials

What exactly are AllovirInc Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include AllovirInc's income statement, its balance sheet, and the statement of cash flows. Potential AllovirInc investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although AllovirInc investors may use each financial statement separately, they are all related. The changes in AllovirInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AllovirInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as AllovirInc is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of AllovirInc has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

AllovirInc December 7, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of AllovirInc help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AllovirInc. We use our internally-developed statistical techniques to arrive at the intrinsic value of AllovirInc based on widely used predictive technical indicators. In general, we focus on analyzing AllovirInc Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AllovirInc's daily price indicators and compare them against related drivers.
Downside Deviation4.81
Information Ratio(0.007569)
Maximum Drawdown27.83
Value At Risk(7.17)
Potential Upside8.89
Please continue to Trending Equities. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for analysis

When running AllovirInc price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
672.6 M
Return On Assets
(0.38) 
Return On Equity
(0.72) 
The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine AllovirInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.